BioMarin
Trade BioMarin 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BMRN
BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307.
BMRN Key Statistics
Stock Snapshot
The current BioMarin(BMRN) stock price is $54.46, with a market capitalization of 10.46B. The stock trades at a price-to-earnings (P/E) ratio of 20.51.
As of 2025-11-17, BioMarin(BMRN) stock has fluctuated between $53.83 and $55.24. The current price stands at $54.46, placing the stock +1.2% above today's low and -1.4% off the high.
The BioMarin(BMRN)'s current trading volume is 2.22M, compared to an average daily volume of 2.36M.
During the past year, BioMarin(BMRN) stock moved between $50.76 at its lowest and $73.51 at its peak.
During the past year, BioMarin(BMRN) stock moved between $50.76 at its lowest and $73.51 at its peak.
BMRN News
BioMarin Pharmaceutical announced that the FDA has accepted for Priority Review its supplemental Biologics License Application to expand PALYNZIQ® treatment for...
